SIVCD8+Tomics

Jennifer Simpson1, Brittany Dulek2, Paul Schaughency2

  • 1Barrier Immunity Section, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.

PLoS pathogens
|September 9, 2024
PubMed
概括

特定于SIV Gag-CM9表位体的CD8+ T细胞没有基于位置或T细胞受体序列的独特转录特征. 然而,这些细胞中的激活途径与感染SIV的的病毒控制相关.

相关概念视频